EXPRESS SCRIPTS PRICE ASSURE
LIVE

Serial Number

97520503

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Troy E. Larson

First Use Date

Jul 15, 2022

Filing Date

Jul 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

EXPRESS SCRIPTS PRICE ASSURE Trademark

Serial Number: 97520503 • Registration: 7281601

EXPRESS SCRIPTS PRICE ASSURE is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on July 26, 2022. The trademark is classified under Class 36 (Insurance & Financial), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

Trademark Details

Filing Date

July 26, 2022

Registration Date

January 16, 2024

First Use Anywhere

July 15, 2022

First Use in Commerce

July 15, 2022

Goods & Services

Prescription drug savings services relating to employer's self-funded prescription programs to provide claim surveillance to identify high cost generic, brand and specialty prescription drugs and provide alternate ways to reduce or eliminate drug costs; Pharmacy benefit management services; providing healthcare benefits optimization information related to healthcare insurance plans; Insurance administration of pharmacy benefit plans; Financial administration of pharmacy reimbursement programs and services

Cost management for prescription drug plans of others in the field of pharmaceuticals; business services, namely, prescription drug formulary cost management services; business administration of pharmacy reimbursement programs and services; providing pharmaceutical, medication, drug, and healthcare information to physicians and pharmacists regarding costs related to the use of generic and name brand products of others; Business consulting services regarding healthcare costs, benefits and pharmacy services; Drug utilization review services; pharmaceutical cost management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level; market analysis and reporting of the effectiveness of tailored health messaging and support at the patient level; providing information in the field of pharmaceutical cost management as provided to pharmacy benefit management services clients, consultants and brokers; providing consumer product and pricing information in the field of pharmaceuticals; Administration of a discount program to allow participants to obtain discounts on the cost of prescription medications through use of a discount card; providing pricing information about the prescription medications of others to others via the global computer network; Business administration of pharmacy benefit plans other than plans concerning insurance and finance; Business services provided to the healthcare industry, namely, analysis of healthcare quality data for business purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 16, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Jan 16, 2024 R.SR
EXPARTE APPEAL TERMINATED
Sep 18, 2023 EXPT
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Aug 11, 2023 AAUA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Aug 10, 2023 CNTA
USE AMENDMENT ACCEPTED
Aug 10, 2023 IUAA
EX PARTE APPEAL-INSTITUTED
Jul 6, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jul 6, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jul 6, 2023 EXAF
TEAS/EMAIL CORRESPONDENCE ENTERED
May 17, 2023 TEME
AMENDMENT TO USE PROCESSING COMPLETE
May 17, 2023 AUPC
USE AMENDMENT FILED
May 17, 2023 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 16, 2023 ERFR
TEAS AMENDMENT OF USE RECEIVED
May 16, 2023 EAAU
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 6, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 6, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 6, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 28, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 28, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 29, 2022 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 29, 2022 NWOS
NEW APPLICATION ENTERED
Jul 29, 2022 NWAP